FDA Adverse Event Injury Summary report: N

C2 CRYOBALLOON ABLATION SYSTEM

MDR report key: 6361363 · Received February 27, 2017

Report

Report Number
3008780134-2017-00003
Event Type
Injury
Date Received
February 27, 2017
Date of Event
January 20, 2017
Report Date
February 27, 2017
Manufacturer
C2 THERAPEUTICS, INC.
Product Code
GEH
UDI-DI
00854924006095
PMA / PMN Number
K161202
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
PA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE DEVICE WAS NOT RETURNED FOR ANALYSIS AND COULD NOT BE FURTHER INVESTIGATED. BASED ON THE INFORMATION REPORTED FROM THE PHYSICIAN, THE DEVICE APPEARS TO HAVE FUNCTIONED AS INTENDED.

Description of Event or Problem · 1

DURING THE (B)(6) 2016 PROCEDURE, 11 ABLATIONS WERE PERFORMED. THE PATIENT REPORTED A PAIN SCORE OF 4 (1 TO 10 SCALE) ON DAY 1 AND 0 ON DAY 7. ON (B)(6) 2017, THE PATIENT CAME TO THE EMERGENCY ROOM WITH DIFFICULTY SWALLOWING FOR 3 DAYS. AN ENDOSCOPY WAS PERFORMED AND SHOWED A BENIGN APPEARING ESOPHAGEAL STENOSIS THAT WAS DILATED. THE PATIENT'S SYMPTOMS IMPROVED, BUT HE WAS UNABLE TO CONSUME A NORMAL DIET THROUGH 4 DAYS POST DILATION. AN ENDOSCOPY WAS PERFORMED ON (B)(6) 2017. THERE WAS A SEVERE BENIGN STENOSIS. THE STRICTURE HAD A 6 MM DIAMETER AND 1 CM LENGTH. COAGULATION FOR TISSUE DESTRUCTION USING A MONOPOLAR PROBE (IT2 KNIFE) WAS PERFORMED. DILATION WITH A 15-16.5-18 MM X 5.5 CM CRE BALLOON DILATOR WAS PERFORMED TO 16 MM, AND THE AREA WAS INJECTED WITH 80 MG OF TRIAMCINOLONE (40 MG/ML, DILUTED UP TO 5 ML). THE STOMACH AND DUODENUM WERE NORMAL. THE PATIENT IS SCHEDULED FOR REPEAT UPPER ENDOSCOPY IN 1 MONTH FOR RETREATMENT. THE PHYSICIAN STATED THAT, "THE STRICTURES WILL OCCUR AFTER ANY MUCOSAL ABLATING THERAPY, THIS EVENT IS NOT LIFE-THREATENING AND AS SUCH I WOULD LIKE TO WAIT AND SEE THE COMPLETE UPDATE IN 2 WEEKS."

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
144040 C2 CRYOBALLOON ABLATION SYSTEM CRYOSURGICAL UNIT WITH ACCESSORIES GEH C2 THERAPEUTICS, INC. FG-1009, FG-1012 06092016-01 00854924006095

Patients

Seq Age Sex Outcome Treatment
1 Other